We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

98 hedge funds and large institutions have $228M invested in Albany Molecular Research Inc in 2013 Q2 according to their latest regulatory filings, with 98 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

49% less call options, than puts

Call options by funds: $317K | Put options by funds: $627K

Holders
98
Holders Change
+98
Holders Change %
–
% of All Funds
3.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
98
Increased
–
Reduced
–
Closed
–
Calls
$317K
Puts
$627K
Net Calls
-$310K
Net Calls Change
-$310K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$31.5M +$28.7M +2,653,195 New
EWM
2
Evercore Wealth Management
New York
$16.6M +$15.1M +1,394,980 New
RA
3
Royce & Associates
New York
$13.1M +$12M +1,103,710 New
BIT
4
BlackRock Institutional Trust
California
$12.7M +$11.6M +1,072,739 New
BFA
5
BlackRock Fund Advisors
California
$10.5M +$9.6M +886,072 New
Allianz Asset Management
6
Allianz Asset Management
Germany
$9.76M +$8.91M +822,285 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$9.46M +$8.63M +796,777 New
ACM
8
American Capital Management
New York
$8.91M +$8.14M +751,000 New
Morgan Stanley
9
Morgan Stanley
New York
$7.98M +$7.28M +672,285 New
Renaissance Technologies
10
Renaissance Technologies
New York
$7.05M +$6.43M +593,642 New
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$6.2M +$5.66M +522,759 New
TC
12
TFS Capital
Pennsylvania
$5.82M +$5.32M +490,638 New
BCM
13
Bridgeway Capital Management
Texas
$5.51M +$5.03M +464,200 New
RFC
14
Russell Frank Company
Washington
$5.06M +$4.62M +426,606 New
BIM
15
Bogle Investment Management
Massachusetts
$5.04M +$4.6M +425,055 New
Wellington Management Group
16
Wellington Management Group
Massachusetts
$4.47M +$4.08M +376,278 New
SFM
17
Systematic Financial Management
New Jersey
$4.46M +$4.07M +375,971 New
Fuller & Thaler Asset Management
18
Fuller & Thaler Asset Management
California
$4.27M +$3.9M +359,750 New
AA
19
Ancora Advisors
Ohio
$3.44M +$3.14M +290,000 New
State Street
20
State Street
Massachusetts
$2.96M +$2.7M +248,966 New
Invesco
21
Invesco
Georgia
$2.91M +$2.65M +245,076 New
EI
22
EAM Investors
California
$2.75M +$2.51M +232,102 New
New York State Common Retirement Fund
23
New York State Common Retirement Fund
New York
$2.39M +$2.18M +201,425 New
Citadel Advisors
24
Citadel Advisors
Florida
$2.13M +$1.94M +179,418 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$2.07M +$1.89M +174,491 New
1
2 3 4

AMRI Hedge Fund Activity: Q2 2013 in Review

98 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q2 2013, worth a combined $228M.

Buyers outnumbered sellers: 98 funds opened new AMRI positions and 0 closed out — a net gain of 98 holders — while 0 added to existing stakes and 0 trimmed.

  • 98 institutional investors held Albany Molecular Research Inc (AMRI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $228M of Albany Molecular Research Inc stock for Q2 2013.
  • 98 funds opened new Albany Molecular Research Inc positions in Q2 2013 and 0 closed out, a net change of +98 holders.

Based on aggregated 13F filings for Q2 2013.